42 related articles for article (PubMed ID: 9647876)
1. c-KIT oncogene expression in PRKAR1A-mutant adrenal cortex.
Nadella K; Faucz FR; Stratakis CA
Endocr Relat Cancer; 2020 Oct; 27(10):591-599. PubMed ID: 32738126
[TBL] [Abstract][Full Text] [Related]
2. Evidence in Favor of an Alternative Glucocorticoid Synthesis Pathway During Acute Experimental Chagas Disease.
da Silva Oliveira Barbosa E; Roggero EA; González FB; Fernández RDV; Carvalho VF; Bottasso OA; Pérez AR; Villar SR
Front Endocrinol (Lausanne); 2019; 10():866. PubMed ID: 31998227
[TBL] [Abstract][Full Text] [Related]
3. Molecular Mechanisms of Primary Aldosteronism.
Tevosian SG; Fox SC; Ghayee HK
Endocrinol Metab (Seoul); 2019 Dec; 34(4):355-366. PubMed ID: 31884735
[TBL] [Abstract][Full Text] [Related]
4. Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study.
Fay AP; Signoretti S; Callea M; Telό GH; McKay RR; Song J; Carvo I; Lampron ME; Kaymakcalan MD; Poli-de-Figueiredo CE; Bellmunt J; Hodi FS; Freeman GJ; Elfiky A; Choueiri TK
J Immunother Cancer; 2015; 3():3. PubMed ID: 25767716
[TBL] [Abstract][Full Text] [Related]
5. Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma.
Elbelt U; Trovato A; Kloth M; Gentz E; Finke R; Spranger J; Galas D; Weber S; Wolf C; König K; Arlt W; Büttner R; May P; Allolio B; Schneider JG
J Clin Endocrinol Metab; 2015 Jan; 100(1):E119-28. PubMed ID: 25279498
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells.
Ziegler CG; Ullrich M; Schally AV; Bergmann R; Pietzsch J; Gebauer L; Gondek K; Qin N; Pacak K; Ehrhart-Bornstein M; Eisenhofer G; Bornstein SR
Mol Cell Endocrinol; 2013 May; 371(1-2):189-94. PubMed ID: 23267837
[TBL] [Abstract][Full Text] [Related]
7. Expression of neuropeptide hormone receptors in human adrenal tumors and cell lines: antiproliferative effects of peptide analogues.
Ziegler CG; Brown JW; Schally AV; Erler A; Gebauer L; Treszl A; Young L; Fishman LM; Engel JB; Willenberg HS; Petersenn S; Eisenhofer G; Ehrhart-Bornstein M; Bornstein SR
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15879-84. PubMed ID: 19717419
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.
Hsiao HP; Kirschner LS; Bourdeau I; Keil MF; Boikos SA; Verma S; Robinson-White AJ; Nesterova M; Lacroix A; Stratakis CA
J Clin Endocrinol Metab; 2009 Aug; 94(8):2930-7. PubMed ID: 19509103
[TBL] [Abstract][Full Text] [Related]
9. [Adrenal gland tumors].
Willenberg HS; Zschucke D; Bornstein SR
Internist (Berl); 2007 Sep; 48(9):971-86. PubMed ID: 17684715
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of hormone receptors in adrenal Cushing's syndrome.
Christopoulos S; Bourdeau I; Lacroix A
Pituitary; 2004; 7(4):225-35. PubMed ID: 16010457
[TBL] [Abstract][Full Text] [Related]
11. Impaired adrenal stress response in Toll-like receptor 2-deficient mice.
Bornstein SR; Zacharowski P; Schumann RR; Barthel A; Tran N; Papewalis C; Rettori V; McCann SM; Schulze-Osthoff K; Scherbaum WA; Tarnow J; Zacharowski K
Proc Natl Acad Sci U S A; 2004 Nov; 101(47):16695-700. PubMed ID: 15546996
[TBL] [Abstract][Full Text] [Related]
12. Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland.
Miyamura N; Taguchi T; Murata Y; Taketa K; Iwashita S; Matsumoto K; Nishikawa T; Toyonaga T; Sakakida M; Araki E
Endocrine; 2002 Dec; 19(3):319-26. PubMed ID: 12624433
[TBL] [Abstract][Full Text] [Related]
13. Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex.
Kero J; Poutanen M; Zhang FP; Rahman N; McNicol AM; Nilson JH; Keri RA; Huhtaniemi IT
J Clin Invest; 2000 Mar; 105(5):633-41. PubMed ID: 10712435
[TBL] [Abstract][Full Text] [Related]
14. [Progress in molecular medicine: "laser capture microdissection"].
Bornstein SR; Willenberg HS; Scherbaum WA
Med Klin (Munich); 1998 Dec; 93(12):739-43. PubMed ID: 10024845
[TBL] [Abstract][Full Text] [Related]
15. Aberrant interleukin-1 receptors in a cortisol-secreting adrenal adenoma causing Cushing's syndrome.
Willenberg HS; Stratakis CA; Marx C; Ehrhart-Bornstein M; Chrousos GP; Bornstein SR
N Engl J Med; 1998 Jul; 339(1):27-31. PubMed ID: 9647876
[No Abstract] [Full Text] [Related]
16. [A case of Cushing's syndrome due to bilateral multiple adrenal adenomas].
Ashida S; Kataoka S; Yamasaki I; Yamashita M; Ohashi Y; Morioka M; Shuin T
Hinyokika Kiyo; 1997 Aug; 43(8):567-70. PubMed ID: 9310779
[TBL] [Abstract][Full Text] [Related]
17. [A case of Cushing's syndrome due to adrenal black adenoma].
Nishida Y; Deguchi T; Hayashi S; Kuriyama M; Ban Y; Kawada Y
Hinyokika Kiyo; 1992 Jan; 38(1):47-50. PubMed ID: 1546569
[TBL] [Abstract][Full Text] [Related]
18. Subclinical Cushing's syndrome due to adrenal myelolipoma.
Boronat M; Moreno A; Ramón y Cajal S; Pineda E; Lucas T; Estrada J
Arch Pathol Lab Med; 1997 Jul; 121(7):735-7. PubMed ID: 9240911
[TBL] [Abstract][Full Text] [Related]
19. [A case of adrenal black adenoma associated with Cushing's syndrome].
Irisawa C; Aikawa K; Ogihara M; Kameoka H; Yamaguchi O; Shiraiwa Y; Hashimoto T; Murakami F
Hinyokika Kiyo; 1991 Aug; 37(8):895-8. PubMed ID: 1957733
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
